English

In this video, Dr. Caralee Caplan-Shaw and her patients clarify the risks of untreated latent TB infection and motivate your patients to complete treatment.

The handout describes the main characteristics of LTBI and Active TB, as well as their differences. The material also describes what increases the risk for developing Active TB and how to prevent TB from developing. 

This guide is designed to explain the safety and efficacy of bedaquiline. It also describes what you as an activist can do to help ensure access, fair pricing and further research. The guide provides messages that regulatory authorities need to hear to prepare for bedaquiline and other new TB drugs.

World TB Day poster available in 5 languages: Creole, English, French, Portuguese, and Spanish

These stories highlight the personal experiences of several people who were diagnosed and treated for TB disease, as well as the work of TB control professionals. You can share individual stories on social media using the social media graphics included on several of the survivor story pages.

The multimedia videos are targeted to community health providers, including those working at Federally Qualified Health Centers. The series contains three videos, each of which is 6 -15 minutes long, and seamlessly incorporate images, voice and text. The videos cover screening, diagnosis and treatment of LTBI. The videos can be viewed from a computer, laptop, smartphone or tablet, where you are - at home, work or on the go. Resources and transcripts are also available.

The goal of the Global Fund (to eliminate AIDS, tuberculosis, and malaria) resonates powerfully with many young people and in response to frequent questions about how they could be involved, the Fund issued a Youth Guide directed especially to their interests. Silhouette illustrations make it racially universal and allow readers to project themselves into the images.

The US Agency for International Development (USAID) has reported to Congress on its international foreign assistance efforts to control tuberculosis (TB). Titled Leading and Leveraging, the report documents work completed the previous fiscal year.

This application, created by the WMA and the New Jersey Medical School Global Tuberculosis Institute, gives physicians the flexibility to access the course material at any time, even when they are discussing treatment options with their patients. The application was developed in collaboration with the World Health Organization with financial support from the Eli Lilly MDR-TB partnership. The application contains the eight training modules which comprise the WMA's course on MDR-TB.

This document revises previous WHO standard case definitions for TB and drug-resistant TB, the categories used to assign outcomes, and the standard reporting framework for TB.